ATE345798T1 - Zusammensetzungen gegen ermüdung enthaltend anserin und d-ribose - Google Patents

Zusammensetzungen gegen ermüdung enthaltend anserin und d-ribose

Info

Publication number
ATE345798T1
ATE345798T1 AT01307418T AT01307418T ATE345798T1 AT E345798 T1 ATE345798 T1 AT E345798T1 AT 01307418 T AT01307418 T AT 01307418T AT 01307418 T AT01307418 T AT 01307418T AT E345798 T1 ATE345798 T1 AT E345798T1
Authority
AT
Austria
Prior art keywords
exercise
ribose
fatigue
composition
compositions containing
Prior art date
Application number
AT01307418T
Other languages
English (en)
Inventor
Yoshiharu Matahira
Kazuaki Kikuchi
Original Assignee
Yaizu Suisankagaku Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2000368299A external-priority patent/JP4873778B2/ja
Priority claimed from JP2001144240A external-priority patent/JP2002338473A/ja
Application filed by Yaizu Suisankagaku Ind Co Ltd filed Critical Yaizu Suisankagaku Ind Co Ltd
Application granted granted Critical
Publication of ATE345798T1 publication Critical patent/ATE345798T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT01307418T 2000-12-04 2001-08-31 Zusammensetzungen gegen ermüdung enthaltend anserin und d-ribose ATE345798T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000368299A JP4873778B2 (ja) 2000-12-04 2000-12-04 抗疲労剤
JP2001144240A JP2002338473A (ja) 2001-05-15 2001-05-15 抗疲労組成物

Publications (1)

Publication Number Publication Date
ATE345798T1 true ATE345798T1 (de) 2006-12-15

Family

ID=26605168

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01307418T ATE345798T1 (de) 2000-12-04 2001-08-31 Zusammensetzungen gegen ermüdung enthaltend anserin und d-ribose

Country Status (7)

Country Link
US (1) US6855727B2 (de)
EP (1) EP1210940B1 (de)
KR (1) KR100805163B1 (de)
CN (1) CN1356103A (de)
AT (1) ATE345798T1 (de)
DE (1) DE60124658T2 (de)
TW (1) TWI221413B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965596A (en) 1997-08-12 1999-10-12 Harris; Roger Methods and compositions for increasing the anaerobic working capacity in tissue
US7504376B2 (en) 1996-08-12 2009-03-17 Natural Alternatives International Methods and compositions for increasing the anaerobic working capacity in tissues
AU2003271144A1 (en) * 2002-10-11 2004-05-04 Ajinomoto Co., Inc. Food compositions for recovery from fatigue
TWI280136B (en) * 2003-05-30 2007-05-01 Lytone Enterprise Inc Composition containing dipeptide of histidine and alanine for reducing uric acid
US20050048136A1 (en) * 2003-08-27 2005-03-03 Choudhry Muhammad S. Rehydrating beverage with Rhodiola crenulata and D-ribose that enhances blood oxygen and relieves post-exertional muscle cramping and soreness
JPWO2005087022A1 (ja) * 2004-03-12 2008-01-24 味の素株式会社 抗ストレス作用を有する食品組成物
JP4792730B2 (ja) * 2004-11-12 2011-10-12 味の素株式会社 抗疲労組成物
DE102005009990A1 (de) * 2005-03-04 2006-09-07 Degussa Ag Salze, Anlagerungs- und Komplexverbindungen der Guanidinoessigsäure
US8536222B2 (en) 2005-03-04 2013-09-17 Alzchem Ag Addition compounds of guanidinoacetic acid
JPWO2006123436A1 (ja) * 2005-05-19 2008-12-25 日本ハム株式会社 運動機能向上性食品
CA2621365C (en) 2005-05-23 2012-09-04 Natural Alternatives International Compositions and methods for the sustained release of beta-alanine
ATE508740T1 (de) * 2006-06-07 2011-05-15 Kyowa Hakko Bio Co Ltd Mittel zur verringerung von müdigkeit
CN101331950B (zh) * 2008-08-05 2012-09-05 北京康比特体育科技股份有限公司 一种提高运动爆发力的营养补剂
JP2012500261A (ja) * 2008-08-20 2012-01-05 バイオエナジー インコーポレイティド 疲労した対象のためのd−リボースの使用
WO2012027277A2 (en) * 2010-08-21 2012-03-01 Hydropep, Llc Compositions for reducing the deleterious effects of stress and aging
CN102038665A (zh) * 2010-11-05 2011-05-04 李晓莉 β-胡萝卜素的应用
CN102318795A (zh) * 2011-10-19 2012-01-18 郭景龙 一种具有抗疲劳作用的保健食品
CN111743999A (zh) * 2013-10-09 2020-10-09 味之素株式会社 抗疲劳组合物
EP3066937B1 (de) * 2013-10-09 2021-01-06 Ajinomoto Co., Inc. Nahrungsmittel mit histidin und anwendung dafür
CN105325821A (zh) * 2014-06-27 2016-02-17 北大方正集团有限公司 一种健康功能型饮料及其制备方法
CN104789623A (zh) * 2015-04-30 2015-07-22 无限极(中国)有限公司 一种蛋白肽的制备方法、蛋白肽及其应用
CN104784210A (zh) * 2015-04-30 2015-07-22 无限极(中国)有限公司 一种具有降尿酸功效的鲣鱼提取物的制备方法及其应用
ITUB20152695A1 (it) * 2015-07-31 2017-01-31 Metis Healthcare S R L Composizione per l'aumento delle secrezioni umorali
CN105996031A (zh) * 2016-05-15 2016-10-12 张雅萍 一种东洋参人参益智药食两用组合物及其制备方法与应用
WO2018115274A1 (en) 2016-12-22 2018-06-28 Universiteit Gent Mixture of dipeptides to improve exercise performance
CN109602893B (zh) * 2018-11-29 2022-05-27 广州白云山明兴制药有限公司 一种改善肝损伤及机体疲劳的组合物及其制剂
CN109965288A (zh) * 2019-04-30 2019-07-05 广西信业生物技术有限公司 一种用于抗运动性疲劳、加快疲劳恢复的组合物及其制备方法
CN111011851A (zh) * 2019-12-26 2020-04-17 北京康比特体育科技股份有限公司 一种抗疲劳的组合物及其制备方法
CN115558692B (zh) * 2022-12-06 2023-04-28 蓝鲲海洋生物科技(烟台)有限公司 一种制备富含鹅肌肽和谷胱甘肽的金枪鱼肽的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028184A (en) * 1972-10-16 1977-06-07 Kikkoman Shoyu Co., Ltd. Process for producing 3',5'-cyclic adenylic acid
JPS58165774A (ja) 1982-03-29 1983-09-30 Ajinomoto Co Inc 飲料組成物
JPS59210871A (ja) 1983-05-16 1984-11-29 Ajinomoto Co Inc 飲料組成物
JPS6094075A (ja) 1983-10-31 1985-05-27 Ajinomoto Co Inc 果汁飲料組成物
JPS61181357A (ja) * 1985-02-08 1986-08-14 Ajinomoto Co Inc ビ−フフレ−バ−の製造方法
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
EP0436611A4 (en) 1988-09-28 1992-03-11 Peptide Technology Ltd Compound and method for the retardation of collagen cross-linking
US6294520B1 (en) * 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
IT1240336B (it) * 1990-03-21 1993-12-07 Setra Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
US5397786A (en) * 1993-01-08 1995-03-14 Simone; Charles B. Rehydration drink
JPH0725838A (ja) 1993-05-13 1995-01-27 Yotsuba Yuka Kk 疲労の予防または回復のための経口投与剤
KR960010020A (ko) 1994-09-09 1996-04-20 도리이 신이치로 조혈 기능 항진제
JP3617102B2 (ja) 1995-01-27 2005-02-02 味の素株式会社 ヒト筋肉疲労の早期回復効果を有するアミノ酸栄養組成物
JPH0920660A (ja) * 1995-07-04 1997-01-21 Suntory Ltd 抗ストレス組成物
JPH0920661A (ja) 1995-07-04 1997-01-21 Suntory Ltd 学習能力向上組成物
ATE245999T1 (de) 1996-01-09 2003-08-15 Riken Aminosäurezusammensetzungen
TW413633B (en) 1996-01-09 2000-12-01 Rikagaku Kenkyusho Amino acid composition
AU4029397A (en) 1996-08-12 1998-03-06 Mark Dunnett Methods and compositions for increasing the anaerobic working capacity in tissues
US5965596A (en) * 1997-08-12 1999-10-12 Harris; Roger Methods and compositions for increasing the anaerobic working capacity in tissue
GB9715340D0 (en) 1997-07-22 1997-09-24 Cerestar Holding Bv Beverages for enhanced physical performance
JPH11322790A (ja) 1998-05-08 1999-11-24 Ajinomoto Co Inc 金属イオン親和性が改善されたタンパク質、その製造方法及びその利用
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
JP2000026290A (ja) 1998-07-07 2000-01-25 Crescendo Corporation:Kk 分岐鎖アミノ酸による筋力維持
JP2000072669A (ja) 1998-08-24 2000-03-07 Inst Of Physical & Chemical Res アミノ酸・糖組成物
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof

Also Published As

Publication number Publication date
US20020103244A1 (en) 2002-08-01
TWI221413B (en) 2004-10-01
EP1210940A2 (de) 2002-06-05
DE60124658D1 (de) 2007-01-04
EP1210940B1 (de) 2006-11-22
CN1356103A (zh) 2002-07-03
US6855727B2 (en) 2005-02-15
DE60124658T2 (de) 2007-09-13
EP1210940A3 (de) 2003-05-07
KR20020043437A (ko) 2002-06-10
KR100805163B1 (ko) 2008-02-21

Similar Documents

Publication Publication Date Title
ATE345798T1 (de) Zusammensetzungen gegen ermüdung enthaltend anserin und d-ribose
JP6933983B2 (ja) 衛生化飲料水と共に使用するためのビタミンeを含有するイソオキサゾリン溶液
CY1108367T1 (el) Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου
ATE324039T1 (de) Verwendung von spinosad oder einer zusammensetzung enthaltend spinosad
MA26960A1 (fr) Sels d'un isothiazole-4-carboxamide et leur utilisation comme agent anti-hyperproliferation
RU2001111880A (ru) Композиции для перорального введения, содержащие луфенурон и нитенпирам, для борьбы с блохами
JP2010138170A (ja) 抗疲労組成物
ZA200506503B (en) Therapeutic agent for diarrhea-type irritable bowel syndrome
EA200601249A1 (ru) Пиперазины, пригодные для лечения боли
KR900018091A (ko) 진경제
ES2083737T3 (es) 4-((2-benzotiazolil)metilamino)-alfa-((3,4-difluorofenoxi)metil)-1-piperidina-etanol.
DE60018545D1 (de) Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen
BR9807330A (pt) Agentes inibidores do progresso de pterìgio e recorrência pós-operatória do mesmo
NZ590800A (en) Compositions for treating rosacea comprising chitosan and a dicarboxylic acid
PL374083A1 (en) Sgk and nedd used as diagnostic and therapeutic targets
JP5776355B2 (ja) 内服液剤
RU2007131934A (ru) Применение 2-(2-нитро-4-трифторметилбензоил)-1,3-циклогександиона при лечении болезни паркенсона
Liao et al. The use of chemicals in aquaculture in Taiwan, Province of China
RU2204383C1 (ru) Способ лечения и профилактики болезней позвоночных животных, вызванных клещами и оводами
WO2005035500A3 (en) Therapeutic agents useful for treating pain
CA2544500C (en) Use of haloarylpyrazole compounds in the control of parasite infestation on animals
GB2609003A (en) Compounds and pharmaceutical compositions for the treatment of metabolic disorders
Yadav et al. Effect of thiazide drug compound on the testicular protein and cholesterol contents of albino rat
BR9912610A (pt) Composições pesticidas
JP2010183914A (ja) 食品組成物

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties